Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Translation

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Activation of the mRNA Decay-Associated DEAD-Box ATPase Dhh1 Requires Deadenylation and Decapping Factors.

bioRxiv : the preprint server for biology·2026

Same author

Suppression of upstream ORF translation is not a widespread mechanism of translational stimulation by yeast helicase Ded1.

Nucleic acids research·2026

Same author

A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response.

Nature communications·2026

Same author

Suppression of upstream ORF translation is not a widespread mechanism of translational stimulation by yeast helicase Ded1.

bioRxiv : the preprint server for biology·2026

Same author

Metabolite import by SLC33A1 is required for ATF6 activation during endoplasmic reticulum stress.

Life science alliance·2026

Same author

Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in post-transcriptional repression of starvation-induced pathways.

eLife·2025

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Targeting translation in hypoxic tumors.

David Ron¹, Alan G Hinnebusch

¹Skirball Institute of Biomolecular Medicine and the Department of Medicine, New York University School of Medicine, New York, New York 10016, USA. ron@saturn.med.nyu.edu

ACS Chemical Biology

|December 14, 2006

Summary

Mammalian cells adapt protein production to low oxygen (hypoxia) by altering their translational machinery. This offers potential to target tumor cells and influence physiological processes.

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Related Experiment Videos

Last Updated: Jul 18, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Area of Science:

Molecular Biology
Cellular Physiology
Cancer Biology

Background:

Mammalian cells possess complex regulatory networks controlling protein synthesis.
Hypoxic conditions, common in tumors, significantly alter cellular metabolism and function.
Understanding cellular adaptation to hypoxia is crucial for therapeutic development.

Purpose of the Study:

To explore the possibility of targeting the translational machinery in mammalian cells under hypoxic conditions.
To investigate the potential for selective inhibition of metabolically compromised tumor cells.
To assess the broader implications for manipulating physiological processes.

Main Methods:

Analysis of recent insights into mammalian cell translational machinery adaptation.
Review of regulatory networks involved in hypoxia response.
Exploration of therapeutic targeting strategies.

Main Results:

Recent findings reveal specific adaptations in the translational machinery of cells exposed to hypoxia.
These adaptations involve intricate regulatory networks that can be potentially targeted.
Selective inhibition of tumor cells with compromised metabolism is a plausible outcome.

Conclusions:

Targeting the hypoxia-induced translational machinery offers a promising strategy for cancer therapy.
This approach may allow for selective elimination of tumor cells while sparing normal tissues.
Further research could unlock broader applications in manipulating physiological processes.